Internal Medicine · Ann Arbor, MI
NPI
1497174551
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1500 E Medical Center Dr, 3rd Floor Taubman Ctr Recp B
Ann Arbor, MI, 48109
Phone (734) 936-5582
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
126,158 services
Medicare patients, 2024
359
Average age 74
Drug cost, 2024
$2.6M
1,140 prescriptions
Company payments, 2025
$1,277
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fares Alsawah was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 36,720 times for 41 patients. In total Fares Alsawah billed 126,158 services in 112 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 36,720 | 41 | $0.27 | $9,905 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,200 | 23 | $44.32 | $629K |
| J0897 Injection, denosumab, 1 mg | Office | 2,700 | 15 | $20.53 | $55K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,470 | 41 | $0.09 | $133 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,190 | 43 | $0.68 | $805 |
| 85025 Blood Count | Office | 775 | 188 | $7.53 | $5,837 |
| 96367 Intravenous Infusion, Hydration | Office | 498 | 57 | $20.51 | $10K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 420 | 14 | $0.26 | $110 |
| 36415 Venipuncture Blood Collection | Office | 376 | 103 | $8.63 | $3,244 |
| 96413 Chemotherapy Administration | Office | 359 | 85 | $92.12 | $33K |
| J9190 Injection, fluorouracil, 500 mg | Office | 275 | 13 | $2.17 | $596 |
| 99213 Office E&M - Established | Office | 270 | 111 | $63.36 | $17K |
| J9045 Injection, carboplatin, 50 mg | Office | 265 | 17 | $2.82 | $746 |
| 96372 Injection Administration | Office | 194 | 64 | $10.32 | $2,003 |
| 96375 Injection Administration | Office | 191 | 54 | $11.13 | $2,125 |
By year: 2022 $283K for 14,024 services; 2023 $1.8M for 124,922 services; 2024 $2.1M for 126,158 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 775 | 188 | $7.53 | $5,837 |
| 36415 Venipuncture Blood Collection | 376 | 103 | $8.63 | $3,244 |
Medicare prescription drug claims, 2024
In 2024, the drug Fares Alsawah prescribed most often to Medicare patients was Anastrozole, with 138 prescriptions and refills. In total Fares Alsawah wrote 1,140 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 138 | 295 | 36 | $3,015 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 72 | 72 | 34 | $1,024 |
| Alendronate Sodium Generic | 52 | 134 | 17 | $356 |
| Tamoxifen Citrate Generic | 47 | 95 | Under 11 | $2,056 |
| Xtandi Enzalutamide | 46 | 46 | Under 11 | $509K |
| Alprazolam Generic | 44 | 46 | 21 | $213 |
| Ondansetron Hcl Generic | 33 | 33 | 19 | $330 |
| Morphine Sulfate Er Morphine Sulfate | 31 | 31 | 12 | $667 |
| Eliquis Apixaban | 30 | 36 | Under 11 | $21K |
| Prednisone Generic | 29 | 29 | 12 | $56.92 |
| Gabapentin Generic | 26 | 27 | 12 | $213 |
| Veozah Fezolinetant | 24 | 24 | Under 11 | $13K |
| Omeprazole Generic | 22 | 29 | Under 11 | $189 |
| Furosemide Generic | 18 | 18 | Under 11 | $28.92 |
| Lorazepam Generic | 17 | 17 | 11 | $67.43 |
Brand drugs: 264 claims; generic drugs: 876 claims; opioid claims: 172.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fares Alsawah $1,277 ($1,277 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novartis Pharmaceuticals Corporation with $229.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $229 |
| Abbvie Inc. ABBV | 4 | $198 |
| Geron Corporation GERN | 1 | $125 |
| Merck Sharp & Dohme LLC MRK | 4 | $104 |
| Janssen Biotech, Inc. JNJ | 4 | $80.37 |
| Genzyme Corporation SNY | 1 | $76.76 |
| Gilead Sciences, Inc. GILD | 3 | $69.51 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $53.25 |
| Caris MPI, Inc. | 1 | $45.71 |
| GlaxoSmithKline, LLC. GSK | 2 | $44.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.